Clare Hayward

Halo Labs

We help our customers reduce development time and improve patient safety by quantifying stability, purity, and quality in protein therapeutics and cell and gene therapy products. Using the latest optics and innovative algorithms, Aura, our flagship product, can analyze and ID sub visible and visible particles, including protein, viral capsid, and cell aggregates. It utilizes a plate-based approach that enables high-throughput (up to 96 samples/run), low-volume (as little as 5 µL) particle analysis in a wide-range of samples from pre-formulation through quality control.